Minireviews
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1056-1067
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1056
Figure 1
Figure 1 Chronic radiation enteritis in a 62-year-old woman with anal cancer. Red arrows indicate regions where radiation enteritis is most evident (personal observation).
Figure 2
Figure 2 Clostridium difficile colitis (red arrow) in a 78-year-old man with a malignant tumor of the lung treated with cyclophosphamide. (personal observation).
Figure 3
Figure 3 Bevacizumab-related intestinal pneumatosis with right colon ischemia in a 69-year-old woman being treated for breast cancer. Red arrows indicate regions where pneumatosis is most evident (personal observation).
Figure 4
Figure 4 Computed tomography images. A: Bevacizumab-related small bowel perforation in a 49-year-old female patient with breast cancer (red arrow); B: Bevacizumab-related late anastomotic leakage (red arrow) in a 72-year-old female colon cancer patient (personal observation).
Figure 5
Figure 5 Computed tomography and intraoperative findings. A: Computed tomography scan of bowel perforation (red arrow) in a 56-year-old male patient undergoing molecular targeted therapy with capozatinib for metastatic renal cell carcinoma; B: Intraoperative findings in the same clinical case (personal observation).
Figure 6
Figure 6 Bowel perforation in a 73-year-old male lung cancer patient undergoing immunotherapy with atezolizumab. The red arrow indicates subdiaphragmatic free air (personal observation).